Vial5-Amino-1MQ 5 mg vial
Fat metabolism
Investigated for NNMT inhibition and adipocyte metabolism.
- Ships from Canada in 1–2 business days
- Free shipping over $120
Place your order, then send the e-Transfer. We pack it as soon as it arrives.
For research use only. Not for human consumption.
Complete your setup
Needles and wipes are free. Water is $19.
- Bacteriostatic Water
$19.00 · To reconstitute the powder
- Needles
Free · For reconstitution
- Alcohol Wipes
Free · To prep the vial stopper
About 5-Amino-1MQ
5-Amino-1MQ is a small molecule studied as an inhibitor of nicotinamide N-methyltransferase, an enzyme associated with fat-cell metabolism and cellular NAD+ availability.
How it works
- NNMT Inhibition
- Studied for inhibiting an enzyme highly expressed in adipose tissue and linked to metabolic rate.
- NAD+ Salvage
- Explored for knock-on effects on the pathway that recycles NAD+ within the cell.
What you need
- Bacteriostatic Water
- Needles
- Alcohol Wipes
- A protocol guide comes with every order
Shipping & payment
- Packed and dispatched within 1–2 business days
- Delivered across Canada in 2–5 business days, tracked
- Temperature-controlled packaging where the product needs it
- Free shipping on orders over $120
- Prices in CAD · pay by Interac e-Transfer
- Format
- Lyophilised powder in a sealed vial
- Strength
- 5 mg per vial
- Storage
- Refrigerate, away from light. Once reconstituted, keep refrigerated and use within the window on the insert.
- Reconstitution
- 2 mL bacteriostatic water for this 5 mg vial (2.5 mg/mL)
- Route in research
- Subcutaneous
- SKU
- 5AM
Handling
- 1ReconstituteAdd bacteriostatic water down the side of the vial. Swirl, never shake. Agitation damages the peptide chain.
- 2StoreRefrigerate at 2–8°C once mixed. Reconstituted peptide is stable for the window given in your protocol guide.
- 3Measure with the calculator Use an insulin syringe at the units your protocol specifies. Rotate sites and log what you take.
- Purity
- High-performance liquid chromatography (HPLC), by an independent laboratory
- Identity
- Mass spectrometry, on the same batch
- How often
- Every batch
- COA
- The certificate of analysis is matched to the lot code printed on your vial
- Evidence
- Preclinical
Check your lot
Every vial carries a lot code. Enter it, or scan the QR on the label, to see its expiry and certificate of analysis.
PreclinicalPublished research on NNMT inhibition, including work relevant to 5-Amino-1MQ, consists of animal and cell studies, and no human clinical trials are identified in the cited literature.
What research examines
- NNMT inhibition in adipose tissue
- Obesity-related metabolic dysfunction in preclinical models
- Adipocyte energy expenditure
- NAD+ salvage pathway effects
- Limb function in experimental peripheral artery disease
Reported in studies
- Human safety data are limited
- Adverse events are not summarized in the cited preclinical studies
- Supplied for laboratory research use only
Published research protocols
5 mg, daily, am
Research protocols have used 2.5–5 mg per administration, once daily (morning), in 8-week blocks with 4 weeks off.
For research use only. These figures summarize published research protocols. They are not instructions or medical advice.
Measure with the calculatorCoreX AI
Ask about 5-Amino-1MQ
Plain answers, from the basics to the studies.
Research information, not medical advice.
Often researched with 5-Amino-1MQ
Researched for weight & body composition.
Vial
Vial
Vial
FAQ
Questions, answered
5-Amino-1MQ is a small molecule studied as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme associated with fat-cell metabolism and cellular NAD+ availability. It is investigated in metabolic enzyme research, mainly in preclinical settings. It is not a peptide in the strict sense, but is commonly grouped with research compounds of interest in metabolic and performance-related studies. CoreX supplies it for laboratory research use only.
Research investigates 5-Amino-1MQ for its inhibition of NNMT, an enzyme highly expressed in adipose tissue and linked to metabolic rate. Blocking NNMT is studied for downstream effects on adipocyte energy expenditure. Researchers have also explored knock-on effects on the NAD+ salvage pathway, which recycles NAD+ within the cell. These mechanisms are proposed from laboratory and animal work, and their relevance in humans has not been established.
Preclinical studies have examined NNMT inhibition in models of obesity-related metabolic dysfunction, reporting effects on metabolic measures in animals. Other animal work has studied NNMT inhibition in experimental peripheral artery disease, with reported improvements in limb function. Broader NNMT research has also looked at the enzyme's role in fatty liver development and in tumour biology. These findings are early and come from animal and cell models rather than human trials.
Human safety data for 5-Amino-1MQ are limited, as research to date has been largely preclinical. Adverse events are not summarized in the cited animal studies, and no controlled human trials establishing a safety profile have been identified. Because of this, conclusions about tolerability, interactions or long-term effects cannot be drawn. The compound is supplied strictly for laboratory research use and is not approved for any medical indication.
Research protocols have used 2.5 to 5 mg per administration, once daily in the morning, via the subcutaneous route, run in 8-week blocks followed by 4 weeks off. These figures describe amounts reported in research protocols and are not recommendations. Each CoreX order ships with a protocol guide for laboratory reference. Given the preclinical status of this compound, such protocols have not been validated in controlled human studies.
You may also like
Vial · Pen
Vial · Pen
Vial
Vial

